this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

COX

4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)BENZENESULFONAMIDE

COX as free ligands, exist in 1 entry. Example includes: 2AW1

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)BENZENESULFONAMIDE
Identifiers4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
FormulaC16 H14 N2 O3 S
Molecular Weight314.36 g/mol
TypeNON-POLYMER
Isomeric SMILESCc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1
InChIInChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)
InChIKeyLNPDTQAFDNKSHK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count36
Chiral Atom Count0
Chiral Atomsn/a
Bond Count38
Aromatic Bond Count19
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00580 Different stereochemistry
NameValdecoxib
Groups
  • investigational
  • withdrawn
DescriptionValdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Brand NamesBextra
Affected OrganismHumans and other mammals
IndicationFor the treatment of osteoarthritis and dysmenorrhoea
PharmacologyValdecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Valdecoxib is used for its anti-inflammatory, analgesic, and antipyretic activities in the management of osteoarthritis (OA) and for the treatment of dysmenorrhea or acute pain. Unlike celecoxib, valdecoxib lacks a sulfonamide chain and does not require CYP450 enzymes for metabolism.
Mechanism of actionBoth COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane. Valdecoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, important for the mediation of inflammation and pain. Unlike non-selective NSAIDs, valdecoxib does not inhibit platelet aggregation.
Categories
  • Amides
  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
ATC-CodeM01AH03
CAS number181695-72-7

Drug Targets

NameSequence SearchPharmacological ActionActions
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...yesinhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682